EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity

Beijing Chen, Mingyang Sun, Chun Zhang, Qi Huang, Dan Teng, Linghao Hu, Huicong Ma, Xinyi Lin, Zan Huang, Renzhao Gui, Xiaobei Hu, Lei Xu und 4 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c01605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Beijing Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Tsuihang New District, Zhongshan 528400, G…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Endopeptidase Clp, Cell Proliferation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, Shanghai Science and Technology Development Foundation, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human sapiens caseinolytic protease P (ClpP) is essential for maintaining mitochondrial proteome homeostasis, and its activation is increasingly recognized as a promising cancer therapy strategy. Herein, based on structure-guided drug design, we discovered a series of potent ClpP activators by introducing a methyl group to the imipridone scaffold of the ClpP activator ONC201 in Phase III clinical trials. Through structural optimization of the lead compound, the most optimal compound, CLPP-1071, exhibited exceptionally potent ClpP agonistic activity (EC50 = 23.5 nM, 107.1-fold stronger than ONC201) and inhibited the proliferation of HL60 cells (IC50 = 4.6 nM, 169.2-fold stronger than ONC201). CLPP-1071 possesses good pharmacokinetic properties and effectively prolongs the lifespan in the MOLM13 and HL60 xenograft models in mice through oral administration. CLPP-1071 is the most potent and orally efficacious ClpP activator reported to date.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsEndopeptidase ClpCell ProliferationHumansAnimalsMiceAdministration, OralStructure-Activity RelationshipXenograft Model Antitumor AssaysCell Line, TumorDrug DiscoveryHL-60 CellsMaleMice, NudeFemale

Substanzen

Antineoplastic AgentsEndopeptidase ClpClpP protein, human

Autor:innen und Institutionen

  • Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Tsuihang New District, Zhongshan 528400, Guangdong, China.
  • School of Pharmacy, Guizhou Medical University, Guiyang 550014, China.
  • School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.
  • School of Pharmacy, Fudan University, Shanghai 201203, China.
  • Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.
  • Department of Medicinal Chemistry, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China.

ORCID-Profile: Mingyue Zheng, Mingliang Wang

Förderung

  • China Postdoctoral Science Foundation
  • Shanghai Science and Technology Development Foundation
  • National Natural Science Foundation of China
  • Creative Research Group of Zhongshan City
  • Guangdong High-level New R&D Institute
  • Guangdong High-level Innovative Research Institute

Zitieren

APA

Chen, B., Sun, M., Zhang, C., Huang, Q., Teng, D., Hu, L., Ma, H., Lin, X., Huang, Z., Gui, R., Hu, X., Xu, L., Zheng, M., Zhou, Y., Li, J., & Wang, M. (2024). Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01605

Vancouver

Chen B, Sun M, Zhang C, Huang Q, Teng D, Hu L, et al. Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01605

BibTeX
@article{Chen2024,
  author = {Chen, Beijing and Sun, Mingyang and Zhang, Chun and Huang, Qi and Teng, Dan and Hu, Linghao and Ma, Huicong and Lin, Xinyi and Huang, Zan and Gui, Renzhao and Hu, Xiaobei and Xu, Lei and Zheng, Mingyue and Zhou, Yubo and Li, Jia and Wang, Mingliang},
  title = {Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c01605}
}
Kostenlos starten →